BCRX BIOCRYST PHARMACEUTICALS INC Insider Trading

Chief Legal Officer Barnes sold 62,500 shares at $5.04 and $9.54 for $596,250.00 under scheduled 10b5-1 plan.

Barnes Alane P, Chief Legal Officer, executed 2 separate sales totaling 62,500 shares for $596,250.00 on 2026-05-13 as part of a pre-arranged 10b5-1 trading plan adopted on 2025-08-13, making this a scheduled, non-discretionary transaction. Post-transaction, Barnes retains 400,703 shares, down from 463,203 shares. Because this transaction is governed by a 10b5-1 plan, it reflects a pre-scheduled execution rather than a discretionary timing decision. BCRX reported revenue of $156,413,000.00 in the latest quarter and annual revenue growth of 94.1%, though the company posted a net loss of $-721,812,000.00, indicating significant cash burn despite top-line expansion.

Chief Legal Officer Barnes Alane P sold 150,000 BCRX shares at $9.15 (150.0K shares) for $1.4M, reducing stake by 27.2%.

Barnes Alane P divested 150,000 shares (27.2% of pre-transaction holdings) at $9.15 on 2026-03-16. The stock currently trades at $9.16, only -18.1% from its 52-week high of $11.19, suggesting the sale occurred near elevated valuation levels. His prior three sells at BCRX show mixed timing: the most recent sell on 2025-12-03 saw the stock rise 13.6% over 90 days, while the two preceding sales in December 2025 yielded +19.6% and +23.2% subsequent returns—all poorly timed from an exit perspective. Against this backdrop of historically unfavorable sell timing at this ticker, the current sale at near-52-week highs merits close monitoring to assess whether this transaction differs from prior patterns or represents continued divergence from optimal exit points. The company's fundamentals remain solid (P/E 6.69, +94.1% annual revenue growth, $12.9M net income), so the disposal likely reflects portfolio management rather than operational concern.

Chief Legal Officer Barnes Alane P sells 161,680 shares of BCRX for $1,164,966.64 across 3 transactions; retains 345,476 shares post-sale

Chief Legal Officer Barnes Alane P executed 3 separate sales totaling 161,680 shares for $1,164,966.64 across December 1–3, 2025, at prices ranging from $7.10 to $7.65 (blended average $7.21), reducing holdings by 31.9% from 507,156 to 345,476 shares. The current price stands at $7.85, modestly above the transaction range, while the stock trades 29.8% below its 52-week high of $11.19. The company posted positive quarterly revenue of $159,395,000.00 and net income of $12,899,000.00, though it remains unprofitable on a full-year basis. Prior BCRX transaction history shows Barnes' May 2024 buy delivered +13.9% 30-day and +38.0% 90-day returns, though this backward-looking pattern does not constrain the timing characterization of the current sell under open-market conditions.